Physician profile
Kevin J Hackett
NPI 1497750897
$3,497.72
in general payments reported to CMS, 2019-2025
32 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,205 · 2020: $138 · 2021: $446 · 2022: $802 · 2023: $332 · 2024: $396 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $986.32 | 2019-2020 | |
| Abbvie INC. | $664.48 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $323.15 | 2021-2025 | |
| Abbott Laboratories | $176.21 | 2022 | |
| Therapeuticsmd, INC. | $140.31 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $123.38 | 2019-2025 | |
| Exact Sciences Corporation | $111.15 | 2023-2025 | Cologuard Collection Kit |
| Coopersurgical, INC. | $108.25 | 2019-2025 | Paragard T 380a |
| Boston Scientific Corporation | $100.60 | 2024 | |
| Sumitomo Pharma America, INC. | $88.57 | 2023-2024 | Myfembree, Orgovyx |
| Exeltis, USA INC. | $68.63 | 2022-2024 | Slynd |
| Organon LLC | $56.58 | 2021-2024 | |
| Daiichi Sankyo INC. | $53.04 | 2020-2022 | |
| Agile Therapeutics, INC. | $49.05 | 2021-2023 | Twirla |
| Medtronic, INC. | $46.83 | 2022-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $42.40 | 2019 | |
| Amag Pharmaceuticals, INC. | $36.02 | 2019-2020 | |
| Pfizer INC. | $35.45 | 2019-2022 | |
| Gynesonics, INC. | $32.37 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Optumhealth Care Solutions, LLC | $30.00 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Lupin INC. | $29.18 | 2020 | |
| Evofem Biosciences, INC. | $27.29 | 2021 | |
| Mylan Pharmaceuticals INC. | $24.33 | 2021 | |
| Allergan, INC. | $22.87 | 2019 | |
| Myovant Sciences INC. | $17.65 | 2021 | |
| Astellas Pharma US INC | $17.58 | 2022 | |
| Aspira Women'S Health INC | $16.70 | 2022 | |
| Millicent US INC | $15.92 | 2024 | Intrarosa |
| Merck Sharp & Dohme LLC | $14.58 | 2021 | |
| Teleflex LLC | $14.16 | 2022 | |
| Hologic INC | $12.61 | 2021 | |
| Minerva Surgical, INC | $12.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Hackett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.